News & Updates

Double whammy: Depression and IBD increase hospital readmission, death

23 Jul 2024 by

Individuals with comorbid depression and inflammatory bowel disease (IBD) are at increased risks for hospital readmission and mortality at 30 days after readmission as shown in a retrospective observational study presented at CCC 2024.

Double whammy: Depression and IBD increase hospital readmission, death

23 Jul 2024

[HKU Medical Grand Rounds] Angels and demons: Immunotherapy for treatment of advanced hepatocellular carcinoma

22 Jul 2024 by

Case 1: A 59-year-old gentleman with advanced HCC was referred to our centre for management. He had a history of diabetes, hypertension and ischaemic heart disease. He was a nondrinker and not a carrier of hepatitis B or C.

Case 2: A 65-year-old man with a history of alcoholic cirrhosis and oesophageal varices was found to have rising AFP levels on routine follow-up. He also had a 3-year history of diabetes and was on diet control, with an HbA_1c of 6.2 percent and fasting glucose of 6.8 mmol/L. He did not need any diabetic medications.

[HKU Medical Grand Rounds] Angels and demons: Immunotherapy for treatment of advanced hepatocellular carcinoma

22 Jul 2024

Early RA-ILD raises mortality risk

22 Jul 2024

Older age and female sex are some of the factors associated with early-onset interstitial lung disease (ILD) in rheumatoid arthritis (RA), reveals a study.

Early RA-ILD raises mortality risk

22 Jul 2024

Adalimumab concentrations negatively linked to inflammatory markers in RA

22 Jul 2024

A negative association exists between adalimumab (ADA) concentrations and markers of inflammatory disease activity in rheumatoid arthritis (RA), including interleukin 6 (IL-6), reveals a study. Notably, ADA concentrations from 5 to 7 mg/L over the dose interval seem to contribute to better disease control.

Adalimumab concentrations negatively linked to inflammatory markers in RA

22 Jul 2024

High CRP level tied to earlier death in ILD

21 Jul 2024 by

Increased levels of serum C-reactive protein (CRP) may contribute to shorter survival in patients with idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis (fHP), rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), or systemic sclerosis (SSc)-associated ILD at 5 years.

High CRP level tied to earlier death in ILD

21 Jul 2024

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

20 Jul 2024

Use of cycline antibiotics (CAs) is associated with an elevated risk of pseudotumour cerebri syndrome (PTCS) or papilledema, suggests a recent study. However, no statistically significant link between CA use and PTCS development is seen when accounting for confounding factors.

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

20 Jul 2024

Ocular complications develop in RA, connective tissue disease, vasculitis patients

20 Jul 2024

Nearly one-fifth of patients with rheumatoid arthritis (RA) develop ocular complications, as do one-quarter to one-third of those with connective tissue diseases and vasculitis, according to a recent study.

Ocular complications develop in RA, connective tissue disease, vasculitis patients

20 Jul 2024

Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19

10 Jul 2024 by

A combination regimen comprising the novel agent GST-HG171 (also known as atilotrelvir) and ritonavir improves clinical symptom recovery and viral clearance in low-risk vaccinated adults with mild-to-moderate COVID-19, findings from a pivotal phase II/III study have shown.

Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19

10 Jul 2024

ITSH article 2.1

08 Jul 2024 by

Bleeding disorders, such as Von Willebrand disease (VWD), platelet function disorder (PFD), thrombocytopenia, and clotting factor deficiencies, are more prevalent among adolescent girls with heavy menstrual bleeding (HMB), according to a study presented at RCOG World Congress 2018.

ITSH article 2.1

08 Jul 2024

ITSH article 2.2

08 Jul 2024 by

Extended clopidogrel monotherapy after a 9- to 12-month course of dual antiplatelet therapy (DAPT) reduces bleeding and ischaemic events in patients with acute coronary syndrome (ACS) who are at high risk for both events, according to the OPT-BIRISK* trial presented at ESC 2023.

ITSH article 2.2

08 Jul 2024

News & Updates

Filter by Specialty:

Specialty:

Double whammy: Depression and IBD increase hospital readmission, death

Double whammy: Depression and IBD increase hospital readmission, death

[HKU Medical Grand Rounds] Angels and demons: Immunotherapy for treatment of advanced hepatocellular carcinoma

[HKU Medical Grand Rounds] Angels and demons: Immunotherapy for treatment of advanced hepatocellular carcinoma

Early RA-ILD raises mortality risk

Early RA-ILD raises mortality risk

Adalimumab concentrations negatively linked to inflammatory markers in RA

Adalimumab concentrations negatively linked to inflammatory markers in RA

High CRP level tied to earlier death in ILD

High CRP level tied to earlier death in ILD

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

Ocular complications develop in RA, connective tissue disease, vasculitis patients

Ocular complications develop in RA, connective tissue disease, vasculitis patients

Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19

Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19

ITSH article 2.1

ITSH article 2.1

ITSH article 2.2

ITSH article 2.2